$5.930
-0.040 (-0.67%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
Loading chart…
該買進 STLN 股票嗎？
Starling Oncology, Inc. is not a good buy right now due to its negative fundamentals and recent performance. The current price is $6.17, and the forward P/E ratio is 0, indicating no expected earnings growth. Additionally, the stock has seen a 5-day change of -4.56%, suggesting a downward trend. The primary risk is the negative P/E ratio of -17.80, which indicates the company is currently unprofitable.
STLN 股價於 Friday 收在 $5.93，此前下跌 -0.67%
(STLN) last closed at $5.93, losing -0.67%. These facts feed the 1-day and 1-week STLN price prediction above.
預測驅動因素
STLN（STLN）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Seasonality
Positive
Bullish
STLN 季節性分析
Loading chart…
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。